Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.61 - $1.84 $73,819 - $222,669
-121,016 Reduced 50.04%
120,841 $167,000
Q4 2021

Feb 11, 2022

BUY
$1.16 - $2.74 $5,916 - $13,974
5,100 Added 2.15%
241,857 $293,000
Q3 2021

Nov 10, 2021

BUY
$2.62 - $5.43 $1,310 - $2,715
500 Added 0.21%
236,757 $620,000
Q2 2021

Aug 12, 2021

BUY
$5.06 - $8.15 $183,693 - $295,869
36,303 Added 18.16%
236,257 $1.25 Million
Q1 2021

May 17, 2021

BUY
$6.24 - $9.58 $190,476 - $292,429
30,525 Added 18.02%
199,954 $1.35 Million
Q4 2020

Feb 16, 2021

BUY
$6.28 - $8.79 $440,485 - $616,539
70,141 Added 70.64%
169,429 $1.15 Million
Q3 2020

Nov 13, 2020

BUY
$7.5 - $11.11 $744,660 - $1.1 Million
99,288 New
99,288 $745,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $11.3M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.